Ticker Details
Arcus Biosciences, Inc.
IPO Date:	March 12, 2018
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.35B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.58 | 2.99%
Avg Daily Range (30 D):	$0.68 | 3.14%
Avg Daily Range (90 D):	$0.58 | 2.75%

Institutional Daily Volume
Avg Daily Volume:	.56M
Avg Daily Volume (30 D):	.94M
Avg Daily Volume (90 D):	1.32M

Trade Size
Avg Trade Size (Sh.):	78
Avg Trade Size (Sh.) (30 D):	62
Avg Trade Size (Sh.) (90 D):	70

Institutional Trades
Total Institutional Trades:	2,810
Avg Institutional Trade:	$2.39M
Avg Institutional Trade (30 D):	$3.2M
Avg Institutional Trade (90 D):	$3.19M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.94M
Avg Closing Trade (30 D):	$3.71M
Avg Closing Trade (90 D):	$5.34M
Avg Closing Volume:	141.14K

News

Dec 2, 2024 @ 3:18 PM Biotech Advances Drive Cancer Research as Global R... Source: Prnewswire

Aug 23, 2024 @ 3:47 PM Retinoblastoma Treatment Market to Surpass $2 Bill... Source: Researchandmarkets.Com

Jul 8, 2024 @ 9:00 PM Cracking The Code: Understanding Analyst Reviews F... Source: Benzinga Insights, Benzinga Staff Writer

Jun 7, 2024 @ 2:55 PM Is The Options Market Predicting a Spike In Arcus ... Source: Zacks Equity Research

Jun 3, 2024 @ 5:59 PM Gilead (GILD), RCUS Announce Data From Colorectal ... Source: Zacks Equity Research

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-3.44	$-1.27	$
Diluted EPS	$-3.44	$-1.27	$
Revenue	$240M	$26M	$160M
Gross Profit
Net Income / Loss	$-341M	$-135M	$M
Operating Income / Loss	$-375M	$-142M	$-8M
Cost of Revenue
Net Cash Flow	$37M	$-10M	$56M
PE Ratio